PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Bone Metabolism10.11005/jbm.2016.23.3.1352016233135An Experimental Study for Minimum Level of Decalcification to Detect the Osteolytic Bone Metastasis of Long Bone on Plain RadiographyJun Ho Baek, Il Hyung Park, Sung Hwa Seohttp://synapse.koreamed.org/pdf/10.11005/jbm.2016.23.3.135, http://synapse.koreamed.org/DOIx.php?id=10.11005/jbm.2016.23.3.135, http://synapse.koreamed.org/DOIx.php?id=10.11005/jbm.2016.23.3.135
Bone10.1016/j.bone.2010.10.0972011481S35Osteolytic versus mixed osteolytic/osteoblastic vertebral metastasis: Comparison of bone structural and remodelling properties in two preclinical rat modelsL. Wise-Milestone*, M.K. Akens, N.K. Thudi, T.J. Rosol, M.D. Grynpas, A. Yee, B. Wilson, C.M. Whynehttps://api.elsevier.com/content/article/PII:S8756328210018016?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S8756328210018016?httpAccept=text/plain
Clinical & Experimental Metastasis10.1007/s10585-008-9212-02008258903-911Inhibition of osteolytic bone metastasis by unfractionated heparinColin K. Yee, Martin Butcher, Melec Zeadin, Jeffrey I. Weitz, Stephen G. Shaughnessyhttp://link.springer.com/content/pdf/10.1007/s10585-008-9212-0.pdf, http://link.springer.com/article/10.1007/s10585-008-9212-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10585-008-9212-0
Bone10.1016/j.bone.2010.10.1192011481S42The causal role of the BMP signalling antagonist noggin in suppressing bone formation in osteolytic bone metastasisC. Secondini*, A. Wetterwald, R. Schwaninger, G.N. Thalmann, M.G. Cecchinihttps://api.elsevier.com/content/article/PII:S8756328210018235?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S8756328210018235?httpAccept=text/plain
Bone10.1016/j.bone.2010.10.1572011481S54-S55Immune interplay between osteolytic disease and bone metastasisA.C. Monteiro, P. Salvador, A.C. Terra Mercadante, A.P. Gregório Alves, A. Balduíno, M.E. Duarte, A. Bonomo*https://api.elsevier.com/content/article/PII:S8756328210018612?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S8756328210018612?httpAccept=text/plain
Bone10.1016/j.bone.2011.03.637201148S259Biochemical markers of bone turnover associated with osteolytic bone metastasisM. Martín-Fernandez, C. Zandueta, K. Valencia, D. Luis-Ravelo, I. Antón, S. Martínez, C. De la Piedra, F. Lecandahttps://api.elsevier.com/content/article/PII:S8756328211007319?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S8756328211007319?httpAccept=text/plain
Bone10.1016/j.bone.2010.10.1532011481S53High-dose antioxidants as potential anti-osteolytic and palliative therapies for breast cancer bone metastasisW. Pfister, T. Blick, S.F. Kok, G. Polekhina, M. Waltham*https://api.elsevier.com/content/article/PII:S8756328210018570?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S8756328210018570?httpAccept=text/plain
Bone10.1016/j.bone.2011.03.431201148S185-S186Chemotherapeutic and anti-resorptive treatments on osteolytic bone at macro- and micro-levelX. Chen, Y.S. Chung, J.C.H. Goh, S. Das De, T. Leehttps://api.elsevier.com/content/article/PII:S8756328211005242?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S8756328211005242?httpAccept=text/plain
Frontiers in Endocrinology10.3389/fendo.2018.0031320189Role of Tumor-Derived Chemokines in Osteolytic Bone MetastasisSalvatore J. Conigliohttps://www.frontiersin.org/article/10.3389/fendo.2018.00313/full
Molecular Therapy10.1016/s1525-0016(16)39138-9200917S298-S299780. Therapeutic Potential of Adult Mesenchymal Stem Cells in Osteolytic Bone Metastasishttps://api.elsevier.com/content/article/PII:S1525001616391389?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S1525001616391389?httpAccept=text/xml